124 related articles for article (PubMed ID: 11798136)
21. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
[TBL] [Abstract][Full Text] [Related]
22. CD8 cytotoxic T cells and the development of new tuberculosis vaccines.
Lalvani A
Am J Respir Crit Care Med; 2002 Sep; 166(6):789-90. PubMed ID: 12231485
[No Abstract] [Full Text] [Related]
23. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
[TBL] [Abstract][Full Text] [Related]
24. The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+gamma/deltaTCR-CD45RO+ T-cell population.
Hogg AE; Worth A; Beverley P; Howard CJ; Villarreal-Ramos B
Vaccine; 2009 Jan; 27(2):270-9. PubMed ID: 18996428
[TBL] [Abstract][Full Text] [Related]
25. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
[TBL] [Abstract][Full Text] [Related]
26. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
27. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
[TBL] [Abstract][Full Text] [Related]
28. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
Weichold FF; Mueller S; Kortsik C; Hitzler WE; Wulf MJ; Hone DM; Sadoff JC; Maeurer MJ
Genes Immun; 2007 Jun; 8(4):334-43. PubMed ID: 17429413
[TBL] [Abstract][Full Text] [Related]
29. Current tuberculosis vaccine development.
Young DB
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S254-6. PubMed ID: 10875794
[TBL] [Abstract][Full Text] [Related]
30. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the human immune response in tuberculosis.
Tsuyuguchi I
Infect Agents Dis; 1996 Mar; 5(2):82-97. PubMed ID: 8721045
[No Abstract] [Full Text] [Related]
32. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.
Hogarth PJ; Logan KE; Vordermeier HM; Singh M; Hewinson RG; Chambers MA
Vaccine; 2005 Apr; 23(20):2557-64. PubMed ID: 15780437
[TBL] [Abstract][Full Text] [Related]
33. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
[TBL] [Abstract][Full Text] [Related]
34. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
35. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
[TBL] [Abstract][Full Text] [Related]
36. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
37. DNA vaccines against tuberculosis.
Lowrie DB
Curr Opin Mol Ther; 1999 Feb; 1(1):30-3. PubMed ID: 11249680
[TBL] [Abstract][Full Text] [Related]
38. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
[TBL] [Abstract][Full Text] [Related]
39. Protection of mice and guinea pigs against tuberculosis induced by immunization with a single Mycobacterium tuberculosis recombinant antigen, MTB41.
Skeiky YA; Alderson MR; Ovendale PJ; Lobet Y; Dalemans W; Orme IM; Reed SG; Campos-Neto A
Vaccine; 2005 Jun; 23(30):3937-45. PubMed ID: 15917115
[TBL] [Abstract][Full Text] [Related]
40. Challenges and solutions for a rational vaccine design for TB-endemic regions.
Gowthaman U; Mushtaq K; Tan AC; Rai PK; Jackson DC; Agrewala JN
Crit Rev Microbiol; 2015; 41(3):389-98. PubMed ID: 24495096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
